N6‐methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO‐PGC‐1α signalling axis.

MLA

Zhuang, Changshui, et al. “N6‐methyladenosine Demethylase FTO Suppresses Clear Cell Renal Cell Carcinoma through a Novel FTO‐PGC‐1α Signalling Axis.” Journal of Cellular & Molecular Medicine, vol. 23, no. 3, Mar. 2019, pp. 2163–73. EBSCOhost, https://doi.org/10.1111/jcmm.14128.

APA

Zhuang, C., Zhuang, C., Luo, X., Huang, X., Yao, L., Li, J., Li, Y., Xiong, T., Ye, J., Zhang, F., & Gui, Y. (2019). N6‐methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO‐PGC‐1α signalling axis. Journal of Cellular & Molecular Medicine, 23(3), 2163–2173. https://doi.org/10.1111/jcmm.14128

Chicago

Zhuang, Changshui, Chengle Zhuang, Xiaomin Luo, Xinbo Huang, Lv Yao, Jianfa Li, Yawen Li, et al. 2019. “N6‐methyladenosine Demethylase FTO Suppresses Clear Cell Renal Cell Carcinoma through a Novel FTO‐PGC‐1α Signalling Axis.” Journal of Cellular & Molecular Medicine 23 (3): 2163–73. doi:10.1111/jcmm.14128.